Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Distinguished FBI and pharmaceutical security expert to lead NanoGuardian advisory board

Abstract:
NanoGuardian™, a division of NanoInk® that focuses on delivering brand protection solutions to fight illegal diversion and counterfeiting, is pleased to announce that John D. Glover, D.P.A., has been appointed to lead its Security Advisory Board. With a distinguished career spanning more than 35 years with the FBI, Bristol-Myers Squibb Company (NYSE: BMY), the Pharmaceutical Security Institute and the U.S. State Department, Dr. Glover will advise NanoGuardian in its efforts to curb the spread of counterfeit and diverted pharmaceuticals in the supply chain.

Distinguished FBI and pharmaceutical security expert to lead NanoGuardian advisory board

SKOKIE, IL | Posted on January 22nd, 2009

In March 1989, Dr. Glover retired from a distinguished career with the FBI, where he investigated, supervised and managed numerous successful high-profile investigations. During his tenure, he was designated executive assistant director for administration at FBI Headquarters in Washington, D.C., one of three direct reports to the director of the FBI.


Later, Dr. Glover served as vice president, corporate security for Bristol-Myers Squibb Company. Among his many accomplishments during this timeframe, Dr. Glover was instrumental in creating the Pharmaceutical Security Institute, an industry-wide, anti-counterfeiting body. He also served as co-chairman of the U.S. State Department's Overseas Security Advisory Council.


Today, Dr. Glover serves as president of John Glover Consulting, Inc., which provides consulting services to a very select number of prominent corporate and non-governmental entities.


"After 35 years of working complex investigations, some of which included chasing counterfeiters and diverters with the FBI, NanoGuardian's on-dose NanoEncryption technology is a product that I can get excited about," said Dr. Glover. "NanoEncryption technology is the only on-dosage, multi-layered, brand protection solution that enables manufacturers to trace and authenticate every single dosage, from plant to patient."


NanoGuardian's NanoEncryption technology possesses intrinsic layered security features at the overt, covert, and forensic level and can be applied directly to tablets, capsules and vial caps. These multi-layered security features enable NanoGuardian to provide a dual-protective benefit to pharmaceutical manufacturers with a single technology. The overt and covert security features enable dose-level authentication at any point in the supply chain, while the forensic NanoCodes provide comprehensive tracing information on each and every tablet, capsule, or vial.


"Dr. Glover's experience as a security expert within the pharmaceutical industry and as the former executive assistant director for administration at the FBI makes him an invaluable resource for us as we work with the pharmaceutical industry, law enforcement, and government to stop counterfeiting and illegal diversion of pharmaceuticals," said Dean Hart, executive vice president of NanoGuardian.


Dr. Glover holds a Bachelor of Arts in Education from Florida A&M University in Tallahassee, Fla. He also received a Master and Doctorate in Public Administration from the University of Southern California.

####

About NanoGuardian™
NanoGuardian™, a division of NanoInk®, focuses exclusively on delivering brand protection solutions to fight illegal diversion and counterfeiting. NanoGuardian’s cutting-edge NanoEncryption™ technology enables manufacturers to authenticate and trace the integrity of their products across the supply chain.

For more information, please click here

Contacts:
Joshua Taustein
Dresner Corporate Services
NanoGuardian
312-780-7219


Sara DeNio
Dresner Corporate Services
NanoGuardian
312-780-7223

Copyright © NanoGuardian™

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Ultrathin device harvests electricity from human motion July 23rd, 2017

The July 23 close fly-by of asteroid 2017 BS5 is explored in a Q&A with Dr. John S. Lewis, chief scientist at Deep Space Industries July 23rd, 2017

Scientists announce the quest for high-index materials: All-dielectric nanophotonics: The quest for better materials and fabrication techniques July 22nd, 2017

Pulses of electrons manipulate nanomagnets and store information: Scientists use electron pulses to create and manipulate nanoscale magnetic excitations that can store data July 21st, 2017

Law enforcement/Anti-Counterfeiting/Security/Loss prevention

Leti Announces Backside Shield that Protects Microchips from Physical Attacks March 8th, 2017

NUS engineers develop low-cost, flexible terahertz radiation source for fast, non-invasive screening: Novel invention presents promising applications in spectroscopy, safety surveillance, cancer diagnosis, imaging and communication February 1st, 2017

Strength of hair inspires new materials for body armor January 18th, 2017

Dressing a metal in various colors: DGIST research developed a technology to coat metal with several nanometers of semiconducting materials January 17th, 2017

Announcements

Ultrathin device harvests electricity from human motion July 23rd, 2017

The July 23 close fly-by of asteroid 2017 BS5 is explored in a Q&A with Dr. John S. Lewis, chief scientist at Deep Space Industries July 23rd, 2017

Scientists announce the quest for high-index materials: All-dielectric nanophotonics: The quest for better materials and fabrication techniques July 22nd, 2017

Pulses of electrons manipulate nanomagnets and store information: Scientists use electron pulses to create and manipulate nanoscale magnetic excitations that can store data July 21st, 2017

Appointments/Promotions/New hires/Resignations/Deaths

Nanometrics Announces Retirement Plans of CEO Timothy Stultz: Dr. Stultz to Continue as Director May 25th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Francis Alexander Named Deputy Director of Brookhaven Lab's Computational Science Initiative February 16th, 2017

Nanobiotix appoints senior executive from pharmaceutical industry, as Chief Operating Officer: Oncology industry veteran to oversee operations and product commercialization February 8th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project